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A B S T R A C T
The electrocardiogram (ECG) is invaluable in providing diagnosis, prognosis, and 
information for decision making in the management of patients with congestive heart 
failure (CHF). In addition to the traditional applications of the ECG, which are of 
importance in the management of patients with CHF, and include indeed the bulk of 
ECG derived information, a recently described association of peripheral edema with 
attenuated ECG voltage, provides an expanded dimension in diagnostics. These at-
tenuations result in decreased amplitude of QRS complexes, P-waves, and shortened 
duration of QRS complexes and QT intervals, with significant diagnostic implications. 
Alleviation of peripheral edema in response to diuresis in patients with CHF reverses 
all above alterations.
I N T R O D U C T I O N
The electrocardiogram (ECG) has many established applications useful for the 
diagnosis, management, and follow-up of patients with congestive heart failure (CHF). 
Since CHF can be the outcome of many pathophysiological derangements, the ECG 
of such patients may show a large range of abnormalities. Occasionally patients with 
CHF may have a normal ECG, or merely show sinus tachycardia without any other 
abnormalities. More commonly however, the ECG of patients with CHF may reveal 
left ventricular hypertrophy (LVH), all types of atrial and ventricular arrhythmias, 
atrio-ventricular and intra-ventricular conduction blocks, evidence of myocardial 
ischemia and/or myocardial infarction, right ventricular hypertrophy, and left and 
right atrial abnormalities; indeed it is safe to state that almost any ECG tracing 
contained in a comprehensive electrocardiography text1 could be seen in a patient 
with CHF! Classic examples of ECG abnormalities associated with CHF are LVH, 
evidence for left atrial abnormality, and atrial fibrillation. Along this line of thought 
one may conclude that there are no strictly speaking specific ECG features of CHF, 
since any ECG seen in patients with other clinicopathological entities, can also be 
seen in patients with CHF.
E C G  PA T T E R N S  I N  C O N G E S T I V E  H E A R T  FA I L U R E
An attempt has been made over the years to connect certain ECG appearances to 
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CHF, particularly severe CHF in patients with ischemic and 
nonischemic cardiomyopathy. Such patterns include left bun-
dle branch block (LBBB), left fascicular blocks, particularly 
left posterior fascicular block,2 intraventricular conduction 
delays, low amplitude QRS complexes due to multiple previous 
myocardial infarctions, ventricular aneurysms,3 and a triad 
characterized by low voltage in the limb leads, high voltage 
in the precordial leads, and a R/S ratio <1.0 in lead V4.4 In 
addition, since many patients with CHF receive implantable 
cardioverter/defibrillators (ICDs), pacemakers, and cardiac 
resynchronization systems, a paced ECG pattern (usually 
LBBB-like in appearance) is often encountered. Recently 
the so called “strain pattern” of ST-segment depression and 
T-wave inversion in patients with ECG evidence of LVH was 
reported to be predictive of increased risk of developing CHF, 
and of dying as a result of CHF, even with aggressive blood 
pressure lowering.5 However, the above list is not all-inclusive 
or comprehensive, and if one scrutinizes the literature, many 
more ECG entities may be found that satisfy the role of a 
“somewhat specific for”, or “characteristic of”, or “frequently 
encountered in” patients with CHF, ECG pattern.
E C G  V O L T A G E  A T T E N U A T I O N  I N  C H F  I N 
P R E S E N C E  O F  P E R I P H E R A L  E D E M A
Recently work has been published showing an asso-
ciation of attenuation of the amplitude of QRS complexes,6 
and P-waves,7 shortening of the QRS duration,8 and QTc 
intervals,9 with peripheral edema (PEED), due to a variety 
of clinical conditions. Such ECG changes in the presence of 
PEED may “camouflage” the diagnostic evidence of ECG 
LVH/dilatation,10 and of left and right atrial abnormalities,11 
which were present prior to the development of PEED. 
These PEED-mediated limitations in the assessment of the 
QRS duration and QTc intervals are encountered with both 
manual and automated measurement methods. Since the QRS 
duration is employed as a severity index in the evaluation of 
patients for ICD implantation or cardiac resynchronization 
therapy,12-14 such artificial shortening of the QRS duration 
compromises the diagnostic role of this ECG parameter. 
Also the QTc is artificially shortened with attenuation of 
ECG voltage in patients with PEED, and thus QTc may lose 
its reproducibility, or its diagnostic and prognostic value. It is 
speculated that the performance of both the QRS duration 
and the QTc interval as indices of severity of pathology, or in 
the follow-up of patients with CHF and PEED in previous 
studies might have been compromised by the perturbations in 
the edematous state of the patients, and thus it deserves to be 
looked at anew, in the context of this insight.15 It has also been 
observed that such apparent shortening of the QRS duration 
may artificially ameliorate complete bundle branch blocks and 
intraventricular conduction delays, converting them to ECGs 
showing incomplete bundle branch blocks or intraventricular 
conduction abnormalities, or even normal intra-ventricular 
conduction.16 It should be understood that this shortening of 
QRS duration, and QTc intervals is apparent, as assessed by 
the manual or electronically based measurements; thus these 
alterations are not cardiac, or electrophysiologically mediated, 
and the shortening results from failure of a portion of the 
onset and offset of QRS and QTc intervals to be accounted 
for, due to their reduced amplitude as a result of the overall 
ECG curve voltage attenuation, rendering them unmeasurable 
and indistinguishable from “noise”.8,9 The above noted changes 
in the ECG in the presence of PEED, and their reversion to 
normal with alleviation of fluid overload correlate well with 
changes in weight and can be employed in the diagnosis and 
follow-up of patients with CHF.17-20
M E C H A N I S M  O F  E C G  A T T E N U A T I O N
The mechanism of the attenuation associated with PEED 
appears to be extracardiac in nature, and due to a short-
circuiting effect on the electrical voltage generated at the 
epicardial surface, exerted by the passive volume conductor 
containing the heart; the short-circuiting effect in turn is 
due to the fluid-based reduction of the electrical impedance 
of the volume conductor (low resistivity of the excess fluid). 
The above-described attenuations of the entire ECG curve 
affect patients with CHF when they go through phases of poor 
compensation, accumulating in the process excess fluid, and 
gaining weight. Conversely when patients with CHF respond 
favorably to medical management with effective diuresis, all 
the above changes are reversed.17-21
A T T E N U A T I O N  R E V E R S A L  A N D  C L I N I C A L 
C O R R E L A T E S
In general, ECG diagnostics relying on amplitude and 
duration measurements are expected to be interfered with 
in patients with PEED. In contrast, when fluid overload is 
alleviated, the amplitudes of QRS complexes and P-waves, 
the QRSd, and the QTc intervals are augmented, depending 
on the extent of reduction of the PEED. This return to nor-
malcy or improvement is also reproducibly experienced after 
hemodialysis,7,9,22 by and may be seen in patients with CHF 
and PEED who have end-stage renal failure and undergo 
this procedure.
Attenuation with PEED in patients with CHF correlates 
well with weight gain from fluid overload, and this associa-
tion can be put to work in the diagnosis and follow-up of such 
patients. Perusal of serial ECGs of patients with CHF and 
PEED indicates that the amplitude of QRS complexes are at its 
lowest when the patients show the highest weight and the most 
conspicuous PEED on physical examination. In contrast, the 
amplitude of QRS complexes is at its highest when the patients’ 
weight is at its lowest, and the PEED has responded favorably 
to diuresis17-21 (Fig. 1). The attenuation of ECG voltage/PEED 
concept can be utilized in clinical practice and research, and 
can be employed either via a quantitative treatment of the 
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12-lead ECG,6-11 or by “eye-balling” the amplitude of leads 
I and II, at the patient’s bedside, in the clinic or the office, 
summing the estimates of amplitude from these 2 leads and 
comparing serially such values with gain or loss of patient’s 
weight or clinical evidence of PEED.23
C O N C L U S I O N
In conclusion, this new insight about the link between 
PEED and attenuation of ECG voltage can be employed in 
manifold ways in the diagnosis and management of patients 
with CHF. Obviously measurements from a single ECG are 
not adequate for these purposes, but measurements from se-
rial ECGs of the parameters described above are very useful, 
and provide the opportunity to evaluate patients with CHF 
and PEED, via an inexpensive modality ubiquitously present, 
obtainable at any time, and in any environment, regardless of 
its sophistication, –the 12-lead ECG.
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